Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome

Cellular/molecular imaging dataset — a durable, citable reference into the African DSI DataBank's federated catalog.

Last updated 10/12/2026, 8:27:34 PM

Cite this record

African DSI DataBank. Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome . AFDSI-CELL-5230. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-CELL-5230 Mirrored from data source: BioImage Archive: https://www.ebi.ac.uk/biostudies/studies/S-BIAD2625.Copy citation

@misc{AFDSICELL5230,
  title        = {Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome
},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-CELL-5230}},
  note         = {African DSI DataBank citable identifier AFDSI-CELL-5230; Mirrored from data source: BioImage Archive: https://www.ebi.ac.uk/biostudies/studies/S-BIAD2625}
}

AFDSI-CELL-5230 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.